Tecentriq (Atezolizumab)

Tecentriq (Atezolizumab) Wholesaler

Tecentriq (Atezolizumab) Distributor

Tecentriq (Atezolizumab) Distributor, Wholesaler 

DESCRIPTION:

Tecentriq  (Atezolizumab)  is a fully humanized, engineered monoclonal antibody of IgG1isotype against the protein programmed cell death-ligand 1 (PD-L1).

TECENTRIQ (ATEZOLIZUMAB)  INDICATION AND USAGE: 

  • In May 2016 FDA approved Tecentriq (Atezolizumab) for locally advanced or metastatic urothelial carcinoma treatment after failure of cisplatin-based chemotherapy.
  • In October 2016, FDA approved  Tecentriq (Atezolizumab) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose disease progressed during or following platinum-containing chemotherapy

DOSAGE FORM & STRENGTH:

  • Tecentriq (Atezolizumab) 1200mg/20ml Wholesaler

Rasso Swiss Pharma is a wholesaler, distributor, supplier for Tecentriq (Atezolizumab).

<< Back to products